Spots Global Cancer Trial Database for recurrent extragonadal seminoma
Every month we try and update this database with for recurrent extragonadal seminoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment | NCT00453310 | Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ... | sunitinib malat... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors | NCT00551122 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ... | filgrastim lenograstim pegfilgrastim cisplatin gemcitabine hyd... ifosfamide paclitaxel | 16 Years - 60 Years | University of Southampton | |
| Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors | NCT00957905 | Recurrent Extra... Recurrent Malig... Recurrent Malig... Recurrent Malig... Recurrent Ovari... Stage III Testi... Stage IV Extrag... Stage IV Extrag... Stage IV Ovaria... | Alvocidib Hydro... Fluorouracil Leucovorin Calc... Oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors | NCT00551122 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ... | filgrastim lenograstim pegfilgrastim cisplatin gemcitabine hyd... ifosfamide paclitaxel | 16 Years - 60 Years | University of Southampton | |
| Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors | NCT00070096 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ... | ixabepilone | 16 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors | NCT00453232 | Extragonadal Ge... Teratoma Testicular Germ... | bleomycin sulfa... pegfilgrastim cisplatin etoposide | 18 Years - 40 Years | National Cancer Institute (NCI) | |
| Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin | NCT00423852 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ... | filgrastim carboplatin ifosfamide paclitaxel autologous hema... peripheral bloo... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors | NCT00313599 | Bladder Cancer Brain and Centr... Breast Cancer Esophageal Canc... Extragonadal Ge... Gastric Cancer Lung Cancer Ovarian Cancer Prostate Cancer | lapatinib paclitaxel | 18 Years - | University of California, San Francisco | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer | NCT00002931 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ... | filgrastim carboplatin etoposide ifosfamide paclitaxel autologous bone... bone marrow abl... | 16 Years - 120 Years | City of Hope Medical Center | |
| Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors | NCT00072215 | Extragonadal Ge... Testicular Germ... | cisplatin ifosfamide paclitaxel vinblastine | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors | NCT00957905 | Recurrent Extra... Recurrent Malig... Recurrent Malig... Recurrent Malig... Recurrent Ovari... Stage III Testi... Stage IV Extrag... Stage IV Extrag... Stage IV Ovaria... | Alvocidib Hydro... Fluorouracil Leucovorin Calc... Oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors | NCT00313599 | Bladder Cancer Brain and Centr... Breast Cancer Esophageal Canc... Extragonadal Ge... Gastric Cancer Lung Cancer Ovarian Cancer Prostate Cancer | lapatinib paclitaxel | 18 Years - | University of California, San Francisco | |
| Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors | NCT00070096 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ... | ixabepilone | 16 Years - | National Cancer Institute (NCI) | |
| Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors | NCT00551122 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ... | filgrastim lenograstim pegfilgrastim cisplatin gemcitabine hyd... ifosfamide paclitaxel | 16 Years - 60 Years | University of Southampton | |
| High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy | NCT01172912 | Brain and Centr... Extragonadal Ge... Testicular Germ... | filgrastim pegfilgrastim carboplatin cisplatin dexamethasone etoposide ifosfamide high-dose chemo... laboratory biom... autologous hema... peripheral bloo... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
